3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
7
Gastritis
5
Peptic Ulcer
3
Gastroesophageal Reflux
3
Dyspepsia
3
Breast Neoplasms
3
Barrett Esophagus
3
Stomach Ulcer
2
Colorectal Neoplasms
2
Vomiting
1
Radiation Esophagitis
1
Precancerous Conditions
1
Peptic Ulcer Hemorrhage
1
Neoplasm Metastasis
1
Nausea
1
Lymphoma, B-Cell, Marginal Zone
1
Hemorrhage
1
Head and Neck Neoplasms
1
Gastrointestinal Stromal Tumors
1
Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer
1
Esophagitis
1
Esophageal Neoplasms
1
Dysbiosis
1
Colonic Neoplasms
1
Interventions
Whole-Body Irradiation
6
Peripheral Blood Stem Cell Transplantation
6
Biopsy
6
fludarabine phosphate
5
Immunohistochemistry
5
Epoetin Alfa
5
Cyclophosphamide
5
Tacrolimus
4
Methotrexate
4
Gene Expression Profiling
4
Celecoxib
4
Mycophenolic Acid
3
Microarray Analysis
3
Imiquimod
3
Etoposide
3
Darbepoetin alfa
3
Cyclosporine
3
Colposcopy
3
Busulfan
3
Antilymphocyte Serum
3
Aminolevulinic Acid
3
Tomography, Optical Coherence
2
Sirolimus
2
Polymerase Chain Reaction
2
Methylprednisolone
2
Melphalan
2
Mass Spectrometry
2
Immunoenzyme Techniques
2
Filgrastim
2
Fatty Acids, Omega-3
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Precancerous Conditions
×
Esomeprazole
×
Clear all
NCT00357682
2025-05-01
AspECT
University of Oxford
Phase 3
Completed
2,557 enrolled
17 charts